The Technical Analyst
Select Language :
Rubius Therapeutics Inc [RUBY]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Rubius Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Rubius Therapeutics Inc is listed at the  Exchange

2.70% $0.0570

America/New_York / 29 des 2023 @ 15:49


Rubius Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 5.16 mill
EPS: -1.990
P/E: -0.0286
Earnings Date: Feb 25, 2024
SharesOutstanding: 90.48 mill
Avg Daily Volume: 0.0995 mill
RATING 2023-12-29
B-
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Strong Sell
Return On Asset: Strong Sell
DE: Neutral
P/E: Neutral
Price To Book: Sell
QUARTER GROWTHS
3/214/211/222/223/224/22
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.0286 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
0.00x
Company: PE -0.0286 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.0550 - 0.0590

( +/- 3.51%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-02-24 Appelhans Dannielle Sell 10 385 Common Stock
2023-02-01 Cagnoni Pablo J Sell 8 448 Common Stock
2023-01-31 Appelhans Dannielle Sell 7 500 Restricted Stock Units
2023-01-31 Appelhans Dannielle Buy 7 500 Common Stock
2023-02-01 Appelhans Dannielle Sell 3 878 Common Stock
INSIDER POWER
40.14
Last 96 transactions
Buy: 4 525 378 | Sell: 349 777

Forecast: 01:40 - $0.0250

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.0570 (2.70% )
Volume 0.756 mill
Avg. Vol. 0.0995 mill
% of Avg. Vol 759.39 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Rubius Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Rubius Therapeutics Inc

RSI

Intraday RSI14 chart for Rubius Therapeutics Inc

Last 10 Buy & Sell Signals For RUBY

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Rubius Therapeutics Inc

RUBY

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatment of HPV-positive tumors; and RTX-T1D for treating type 1 diabetes. The company was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
LULUMar 28 - 12:27$391.69
TRMBMar 28 - 12:26$63.32
OSHIUSDMar 28 - 12:2494.91
AGIXUSDMar 28 - 12:241.405
VRNSMar 28 - 12:24$48.21
ACMRMar 28 - 12:24$28.90
TSLQMar 28 - 12:2237.98
FTAIMar 28 - 12:22$67.14
INTCMar 28 - 12:22$44.29
EXPEMar 28 - 12:22$138.29

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.